Mutual Funds

ICICI Pru Long Term Equity: Scoring well on consistency

Nalinakanthi V | Updated on January 13, 2018 Published on February 19, 2017


Long-term investors with a moderately high risk appetite can go for this fund

With the financial year coming to a close in a month,Equity Linked Savings Scheme (ELSS) may be a good way to diversify your investment. ICICI Prudential Long Term Equity is one that boasts of a consistent performance record in this category.

However, given that ELSS schemes, in general, have a three-year lock in, this will suit investors with a five-year horizon and a moderately high risk appetite. The fund scores well on consistency. In the last five years, the scheme’s one-year return has been better than its benchmark — Nifty 500 Index almost 90 per cent of the time.

In the past, the fund has been able to contain downsides well during weak phases. For instance, during the January-August 2013 period, the scheme lost less than 14 per cent, compared with an almost 17 per cent fall in its benchmark. Reducing exposure to cyclical themes such as financials and loading up on less-volatile pharma and IT helped. The fund’s strategy to stay away from momentum stocks has also helped performance.

Rallying right

Likewise, during rally phases too, the fund has managed to deliver benchmark-beating returns. Consider the September 2013-April 2015 period. The fund’s NAV almost doubled even as the benchmark rose by about 80 per cent. Ability to move quickly into cyclical themes aided the sharp recovery.

Besides right stock and sector shifts, flexibility to shift across market cap curves and a low expense ratio (2.3 per cent) compared with peers Franklin India Taxshield (2.48 per cent) and Principal Tax Savings (2.56 per cent) also aided performance.

Over three, five and ten-year time frames, the fund has delivered returns 4-5 percentage points higher than its benchmark. However, the fund’s one-year performance has not kept pace with its benchmark — Nifty 500 Index. Given the higher-than-benchmark exposure to pharma stocks, the sharp correction in these stocks in the last three months impacted the scheme’s performance. IPCA Laboratories and Alembic Pharma held by the fund, dropped 14-16 per cent.The fund added large cap pharma stocks — Sun Pharmaceuticals and Lupin — during this period. The weakness in the former, following a muted performance in the December 2016 quarter did not help.Other stock bets that hurt performance include Orient Cement, Thomas Cook, Container Corporation and Infosys. These stocks shed 7-25 per cent. George Heber Joseph took charge as fund manager in November 2015; the fund’s performance from November 2015 till date has been in line with its benchmark.

Published on February 19, 2017

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.